Kathryn A. Giblin

The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes

Stephen J. Atkinson, Peter E. Soden, Davina C. Angell et al. · MedChemComm · 2014 · 73 citations

Epigenetic Change, Molecular Biology, Epigenetics +22

DockStream: a docking wrapper to enhance de novo molecular design

Jeff Guo, Jon Paul Janet, Matthias R. Bauer et al. · Journal of Cheminformatics · 2021 · 71 citations · Full text

Drug Target, Engineering, Molecular Biology +20

De novo design with deep generative models based on 3D similarity scoring

Kostas Papadopoulos, Kathryn A. Giblin, Jon Paul Janet et al. · Bioorganic & Medicinal Chemistry · 2021 · 38 citations

Systems Biology, Engineering, Machine Learning +8

Prospectively Validated Proteochemometric Models for the Prediction of Small-Molecule Binding to Bromodomain Proteins

Kathryn A. Giblin, Samantha Jane Hughes, Helen Boyd et al. · Journal of Chemical Information and Modeling · 2018 · 19 citations

Bromodomain-containing Proteins, Bromodomain Proteins, Molecular Biology +22

New Associations between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety Targets

Kathryn A. Giblin, Danilo Basili, Avid M. Afzal et al. · Chemical Research in Toxicology · 2020 · 15 citations · Full text